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Abstract
We consider an additive model with a main effect and effects from multiple treatments. Our
goal is to estimate the heterogeneous treatment effects among patients. Traditionally, one
can fit standard regressions in which models for the main effect and the treatment effects are
specified. However, mis-specification of either the main or the treatment effects could severely
undermine the estimation. A set of recent proposals directly estimate the treatment effect,
avoiding the potential mis-specification issue for the main effect. However, performance of
these methods rely on either a known or accurate estimator of the propensity score. In this
paper, we propose a doubly robust direct learning method (RD-Learning) to estimate the
treatment effect. The double robustness comes form the fact that it is robust to the two issues
of (1) main effect mis-specification and (2) inaccurate propensity score estimates. As long as
these two do not occur at the same time, our estimate is consistent and has a smaller variance
than competing methods. It can be used in both the binary and the multi-arm settings. As
a by-product, we develop a competitive statistical inference tool for the treatment effect,
assuming the propensity score is known. We provide theoretical insights to the proposed
method using risk bounds under both linear and non-linear settings. Our method is further
demonstrated by simulation studies and a real data example.
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1 Introduction
Identifying heterogeneity in treatment effects is an important topic in precision medicine. For
example, drug developers tag useful chemical compounds with high treatment effects; health
care provides prescribe the best treatment to each individual patient. In this paper, we aim to
estimate the difference between the conditional mean outcome given the covariate information for
an individual subject and any of two treatments. This problem is typically known as estimation
of Individualized Treatment Effect (ITE) or Conditional Average Treatment Effect (CATE).
There is a vast literature on ITE estimation. Two major types of approaches have been
widely used. The first type is model-free local-based prototype methods, such as nearest-neighbor
matching (Crump et al., 2008), and causal forests (Wager and Athey, 2018). The second type is
model-based analytical methods. For example, in Q-Learning (Watkins and Dayan, 1992; Mur-
phy, 2005; Qian and Murphy, 2011; Moodie et al., 2014), a conditional mean outcome is first
estimated for each treatment, then ITE is constructed by taking their differences. However, these
estimation are subject to model mis-specification, which often includes both the model for the
main effect and the model for the treatment effect. A-Learning (Murphy, 2003; Robins, 2004) and
D-Learning (Tian et al., 2014; Qi et al., 2018) address this issue by estimating the treatment effect
directly imposing no model on the main effect, hence avoiding mis-specifying the latter. However,
the success of both A-learning and D-learning rely on an accurate (or known) propensity score.
Otherwise, the estimated ITE may be inconsistent. There are also procedures for estimating ITE
based on Bayesian framework, for example, Bayesian Additive Regression Trees (Chipman et al.,
2007, 2010; Hill, 2011).
Augmented Inverse Propensity Weighted Estimator (AIPWE), a robust estimator, was pro-
posed (Robins et al., 1994; Rotnitzky et al., 1998; Scharfstein et al., 1999) to estimate the (un-
conditional) Average Treatment Effect (ATE) over the population. AIPWE has a nice “double
robustness” property in the sense that as long as the model for either the conditional outcomes or
the propensity score is correctly specified, the estimator is consistent. Note that AIPWE is not
conditional on individual subjects. There are several recent proposals in personalized medicine
with double robustness. For example, Zhang et al. (2012) proposed a framework to estimate the
optimal treatment regime by using AIPWE as the objective function. Zhao et al. (2019) con-
structed the Individualized Treatment Rule (ITR) by treating AIPWE as the weight to solve a
1
weighted classification problem. For other related work, refer to Bang and Robins (2005); Kang
et al. (2007); Cao et al. (2009); Zhang et al. (2013); Zhao et al. (2014); Zhang et al. (2015); Fan
et al. (2016); Huang et al. (2019). Most of these procedures are designed for two-arm studies.
Doubly robust methods for the multi-arm setting, such as Zhang et al. (2015) and Huang et al.
(2019), mainly focus on estimating ITR rather than ITE. Secondly, among the doubly robust esti-
mators for ITE, most of them are based on AIPWE, which requires estimation of the conditional
mean outcome for each arm before estimating ITE. See, for example, Funk et al. (2011) and Lee
et al. (2017).
In this paper, we propose Robust Direct Learning (RD-Learning) to estimate ITE. This is an
improvement based on the D-Learning framework. The method differs from all the aforementioned
doubly robust procedures in that it is not based on AIPWE. Specifically, instead of having to
estimate the conditional mean outcome for each treatment arm before ITE estimation, we only
need to estimate the main effect model. The consistency for ITE is guaranteed if either the
main effect model or the propensity score model is correctly specified. Secondly, we generalize
the method to the multi-arm case by making use of the angle-based multi-category classification
method. Moreover, we consider a special setting with known propensity scores, in which case,
we propose an efficient estimator for the main effect and an unbiased estimator for the treatment
effect, and derive the asymptotic normality which affords statistical inference.
The rest of the paper is organized as follows. In Section 2, we introduce some notations and
background. We present the proposed RD-Learning method in Section 3. Statistical inference in
the known propensity score setting can be found in Section 4. In Section 5, we design simulation
studies to validate the proposed method, followed by a real data example on AIDS clinical trial in
Section 6. Section 7 concludes the paper. All technical proofs are provided in the supplementary
material.
2 Notations and Background
First consider a two-arm randomized trial. A patient, with pre-treatment covariate X ∈ X ⊆ Rp,
is randomly assigned to treatment A ∈ A = {1,−1}. Let Y ∗(j) ∈ R be the potential outcome the
patient would receive by receiving treatment j ∈ A. The observed clinical outcome is denoted by
Y = Y ∗(A). Let pj(x) = P(A = j |X = x). Assumption 1 is a typical regularity assumption.
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Assumption 1. For any j ∈ A, Y ∗(j) ⊥ A |X and pj(x) ≥ c for some c ∈ (0, 1).
Let P be the distribution of the triplet (X, A, Y ). The goal is to estimate the Individualized
Treatment Effect (Chen et al., 2017, ITE), defined as
E(Y ∗(1)− Y ∗(−1) |X = x),
based on a training sample {(xi, ai, yi)}ni=1 randomly drawn from P .
It is typical to consider the following model,
Y = m(X) + Aδ(X) + , where E() = 0, Var() = σ2 <∞. (1)
Denote the conditional mean outcome as µj(x) , E(Y ∗(j) | X = x) = E(Y | X = x, A = j). It
can be easily verified that the main effect m(x) = (µ1(x) + µ−1(x))/2, and the treatment effect
δ(x) = (µ1(x) − µ−1(x))/2. Thus, to estimate ITE is equivalent to to estimate δ(x). In this
article, we refer to δ(x) as the treatment effect.
One way to estimate δ(x) is to conduct regression modeling for µj(x), j ∈ {1,−1}. This
approach is known as Q-Learning (Murphy, 2005; Qian and Murphy, 2011), where µj(x) is referred
to as the “Q function”. For example, one may consider linear regression models for µj(x) which
imply linear modeling for both m(x) and δ(x), such as m(x) = xTα and δ(x) = xTβ with
x = (1,xT )T ∈ Rp+1. The coefficients are estimated by solving the following optimization problem,
min
α,β∈Rp+1
1
n
n∑
i=1
(yi − xTi α− aixTi β)2.
This approach may be vulnerable to model mis-specification ofm(x) and δ(x). A partial solution is
to consider a broader model space (e.g. non-parametric models) to avoid model mis-specification.
Tian et al. (2014) proposed a new method to estimate δ(x) without specifying the model
for m(x) under the completely randomized trail setting, i.e., p1(x) = 1/2. By observing that
E(AY | X = x) = δ(x), we may use a linear function xTβ to model E(AY | X = x) directly.
Chen et al. (2017) considered a more general framework to accommodate other proportion p1(x)
than 1/2, as well as observational studies. Specifically, for linear modeling, the treatment effect
δ(x) is estimated by xβˆ where
βˆ = argmin
β∈Rp+1
1
n
n∑
i=1
1
pai(xi)
(aiyi − xTi β)2 = argmin
β∈Rp+1
1
n
n∑
i=1
1
pai(xi)
(yi − aixTi β)2. (2)
This estimator has been proved to be consistent under Assumption 1. Unlike Q-Learning, in which
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the estimator to δ(x) is based on the estimators for µj(x)’s, this approach directly estimates the
treatment effect δ(x). Hence, it is named Direct Learning or D-Learning (Qi et al., 2018). Non-
linear or sparse modeling is also possible in this framework.
One advantage of D-Learning over Q-learning is that it avoids mis-specification of the main
effect m(x). However, existing consistency results for D-Learning assume that the propensity
score pj(x) is known or at least correctly specified, which may not be satisfied in observational
studies. Moreover, as will be shown later, the D-Learning estimator also suffers a larger variance
compared to other methods.
3 RD-Learning
We first introduce our proposed Robust Direct Learning (RD-Learning) approach for the binary
case, then generalize it to the multi-arm case. This is followed by the theoretical study of the
proposed method.
3.1 RD-Learning in the Binary Case
Given a training sample {xi, ai, yi}ni=1, the RD-Learning method is based on an estimator for the
propensity score p1(x), denoted by pˆ1(x), and an estimator for the main effect m(x), denoted by
mˆ(x). They can be any existing estimators commonly used in the literature. If we consider linear
modeling for the treatment effect, i.e., δ(x) = xβ, then RD-Learning estimator for β is obtained
by solving
βˆ = argmin
β∈Rp+1
1
n
n∑
i=1
1
pˆai(xi)
(yi − mˆ(xi)− aixTi β)2, (3)
where xi , (1,xTi )T , and the treatment effect is estimated by δˆ(x) = xT βˆ.
A major difference between (3) and (2) is that RD-Learning replaces yi in D-Learning by
a residual yi − mˆ(x). In the literature, similar procedures have been proposed in many other
methods. For example, Shi et al. (2016) and Nie and Wager (2017) proposed Robust Learning to
estimate δ(x) by replacing yi in A-Learning (Murphy, 2003; Robins, 2004) with yi− Φˆ(xi), where
Φˆ(x) is an estimator for E(Y |X = x). In the literature of Individualized Treatment Rule (ITR),
similar efforts have been made to improve Outcome Weighted Learning (Zhao et al., 2012, OWL)
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using Residual Weighted Learning (Zhou et al., 2017, RWL), where the latter one replaces the
outcome yi in OWL by yi − mˆ(xi). In general, such procedures can reduce the variance of the
estimators. Even when Φˆ(x) or mˆ(x) is mis-specified, the estimators are still consistent as long
as the propensity score pˆ1(x) can be consistently estimated. That is to say, these estimators are
robust against model mis-specification with respect to Φ(x) or m(x). The RD-Learning method
that we propose here to estimate ITE also enjoys this robustness property. Beyond that, it has
an additional “double robustness” property, which is described in the following theorem.
Theorem 1. Suppose model (1) holds. Let p˜1(x) be a working model for the propensity score
p1(x) with 0 < p˜1(x) < 1 and m˜(x) be a working model for the main effect m(x). Assume that
Assumption 1 holds. Then we have
δ ∈ argmin
f∈{X→R}
E
[
1
p˜A(X)
(Y − m˜(X)− Af(X))2
]
if either p˜1(x) = p1(x) or m˜(x) = m(x) for x ∈ X almost surely.
Theorem 1 also holds when, the functions p˜1(x) and m˜(x) are replaced by the limiting functions
of estimators pˆ(x) and mˆ(x). This suggests that the empirical version of the minimizer above δˆ(x)
(whose definitions are given in (3) and in Section 3.2) will be consistent with δ(x) if either pˆ1(x)
or mˆ(x) is consistent. Compared to the aforementioned robustness procedures, this estimator is
robust again two types of model mis-specification, with respect to both p1(x) and m(x). We call
this property “double robustness”.
To compare RD-Learning and D-Learning, we compute the bias and the variance of the es-
timators from these two methods. Denote X = (x1, . . . ,xn)
T , y = (y1, . . . , yn)
T , and m(X) =
(m(x1), . . . ,m(xn))
T . Let A = diag(ai), and Pa = diag(pˆai(xi)), from (3) we derive
βˆ = (XTP−1a X)
−1XTAP−1a (y − mˆ(X)). (4)
Let r(X) = m(X)− mˆ(X) be the difference between the true main effect and its estimator. It can
be shown that
E(βˆ | X,A) = β + (XTP−1a X)−1XTAP−1a r(X), (5)
Var(βˆ | X,A) = σ2(XTP−1a X)−1XTP−2a X(XTP−1a X)−1, and
Var(βˆ | X) = Var
(
(XTP−1a X)
−1XTAP−1a r(X) | X
)
+ E
(
Var(βˆ | X,A) | X
)
. (6)
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Note that D-Learning can be viewed as a special case of RD-Learning, where mˆ(xi) = 0 for all i,
in which case r(xi) = m(xi). Firstly, from (5) we observe that the estimator by RD-Learning has
a smaller bias if |r(xi)| < |m(xi)| holds. In the extreme that mˆ(x) = m(x) which means that
r(x) = 0, the RD-Learning estimator βˆ is an unbiased estimator. Secondly, from (6) we notice
that RD-Learning also has a smaller variance. This is because in general the variability of the
residual term r(X) is smaller than that of m(X), which results in a smaller value in the first term
of (6). The smallest variance is achieved when r(x) = 0 (perfect estimation of m(x).)
For high dimensional data, RD-Learning can be generalized by using a sparsity penalty. For
example, we may solve a LASSO problem,
min
β∈Rp
β0∈R
1
n
n∑
i=1
1
pˆai(xi)
(
yi − mˆ(xi)− ai(xTi β + β0)
)2
+ λ‖β‖1 (7)
with the tuning parameter λ > 0. To adopt a richer model space, we could also consider a non-
linear function form for δ(x). For example, we may solve a kernel ridge regression problem as
follows.
min
β∈Rn
β0∈R
1
n
n∑
i=1
1
pˆai(xi)
(
yi − mˆ(xi)− ai(KTi β + β0)
)2
+ λβTKβ,
where Ki is the ith column of the gram matrix K = (K(xi,xj))n×n, with K(·, ·) a kernel function.
Other non-linear regression models such as generalized additive model and gradient boosting can
be applied in the RD-Learning framework.
Figure 1 compares Q-Learning, D-Learning, and RD-Learning using two toy examples. In each
example, the Subpopulation Treatment Effect Pattern Plots (STEPP), a typical visualization
method for exploring the heterogeneity of treatment effects (Bonetti and Gelber, 2000, 2004),
shows the relationship between the estimated ITEs and predictor x1. Case I has a non-linear main
effect and a linear treatment effect, where µj(x) = 2 cos(x1 + pi/4) + (3 − j)x1/2 − tanh(x1) for
j ∈ {1,−1} and p1(x) = 0.2 + 0.61[x1 < 0]. For Q-Learning, we use kernel ridge regression to
estimate µj(·); for D-Learning, we use LASSO as in Qi et al. (2018) to estimate the treatment effect
δ(·); in RD-Learning, we use kernel ridge regression to estimate m(·) and the LASSO estimator
(7) to estimate δ(·). Both the main effect and the treatment effect in Case II have a linear form,
with µj(x) = (3− j)x1/2 + x2 for j ∈ {1,−1} and p1(x) = 1/2. We use LASSO to estimate µj(·),
m(·), and δ(·) in all three methods. Note that the true ITE is µ1(x) − µ−1(x) = −x1 in both
cases. From Figure 1, it is clear that RD-Learning is a robust method. In particular, compared
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to Q-Learning, RD-Learning reduces bias in estimating ITE when the main effect tends to be
mis-specified (Case I). Compared to D-Learning, RD-Learning reduces variance in both examples.
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Figure 1: Subpopulation Treatment Effect Pattern Plots (STEPP) by different methods on two simulated
data with X ⊆ R20. Blue regions are 95% confidence region based on 200 replications, and the black line
is the true ITE. In both cases RD-Learning has a good performance.
3.2 RD-Learning in Multi-arm Case
In this section, we generalize RD-Learning to the case when there are more than two treatment
arms. Let A ∈ A = {1, . . . , k} be the treatment assignment. We assume the model to be
Y = m(X) + δA(X) + , where
k∑
j=1
δj(x) = 0, E() = 0, Var(|X) = σ2(X) <∞. (8)
As in the binary case, m(·) is the main effect. {δj(·)}kj=1 are the treatment effects, where each of
them measures the difference between the expected outcome of treatment j and the main effect,
i.e., δj(x) = µj(x) − m(x). The sum-to-zero constraint guarantees the model is identifiable.
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We also allow heteroskedasticity in the white noise term  to make the model more general. To
estimate the treatment effect δj(x), we consider the following angle-based approach.
Angle-based approach (Zhang and Liu, 2014) is a method used in multicategory classification
problem and recently it has been introduced to solve a multicategory ITR problem (Zhang et al.,
2018; Qi et al., 2019). In the angle-based framework, we represent k arms by k vertices of a
(k − 1)-dimensional simplex, denoted by W1, . . . ,Wk:
Wj =
(k − 1)
−1/21k−1, j = 1
−(1 + k1/2)(k − 1)−3/21k−1 + [k/(k − 1)]1/2 ej−1, 2 ≤ j ≤ k,
where 1k−1 is a (k − 1)-dimensional vector with all elements equal to 1 and ej−1 ∈ Rk−1 is a
vector with the (j − 1)th element 1 and 0 elsewhere. It is easy to check that ‖Wj‖ = 1 and the
angle ∠(Wi,Wj) is the same for all i 6= j. The angle-based approach uses a (k − 1)-dimensional
vector-valued function f(x) = (f1(x), . . . , fk−1(x))T as the decision function. In an ITR problem,
by computing the angles between f(x) and these vertices Wjs, the optimal treatment for patient
with covariates x is chosen to be argminj∈A∠(Wj,f(x)).
Note that for any f(x) ∈ Rk−1, the sum-to-zero constraint is satisfied for the inner prod-
ucts implicitly,
∑k
j=1〈Wj,f(x)〉 = 0. On the other hand, for treatment effects {δj(x)}kj=1 with∑k
j=1 δj(x) = 0, there is a unique f(x) ∈ Rk−1 such that 〈Wj,f(x)〉 = δj(x) for j ∈ A. This
motivates us to estimate the treatment effect δj(x) by 〈Wj,f(x)〉 in the angle-based framework.
Theorem 2. Suppose model (8) holds. Let p˜j(x) > 0 be a working model for pj(x) and m˜(x) be
a working model for m(x). Define
f ∗ ∈ argmin
f∈{X→Rk−1}
E
[
1
p˜A(X)
(Y − m˜(X)− 〈WA,f(X)〉)2
]
.
Under Assumption 1, if either p˜j(x) = pj(x) or m˜(x) = m(x) holds for x ∈ X almost surely and
all j ∈ A, then δj(x) = 〈Wj,f ∗(x)〉 except on a set of measure zero.
By Theorem 2, we propose the angle-based RD-Learning 1 by solving
min
f∈F
1
n
n∑
i=1
1
pˆai(xi)
(yi − mˆ(xi)− 〈Wai ,f(xi)〉)2, (9)
where F is a function space. For example, we may let F to be the linear space, i.e.F = {f =
1Angle-based D-Learning has been studied in Qi et al. (2019) with a different formulation.
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(f1, . . . , fk−1)T ; fj(x) = xTβj, j = 1, . . . , k − 1}; or, we may consider F in a Reproducing Ker-
nel Hilbert Space (RKHS) with kernel function K(·, ·), i.e.F = {f = (f1, . . . , fk−1)T ; fj(x) =∑n
i=1K(xi,x)βij + β0j, j = 1, . . . , k− 1}. An L1 or L2 norm constraint can be also added to f to
prevent overfitting. Denote the solution of (9) by fˆ . Then the estimator for jth treatment effect
is given by
δˆj(x) = 〈Wj, fˆ(x)〉. (10)
Note that the binary RD-Learning introduced in Section 3.1 is a special case of the angle-based
RD-Learning. Note that when k = 2, we have W1 = 1 and W2 = −1. So 〈Wa, f(x)〉 = f(x) for
a = 1 and 〈Wa, f(x)〉 = −f(x) for a = 2 thus (9) reduces to (3) for the linear function space.
3.3 Theoretical Analysis of RD-Learning
In this section, we study the theoretical property of δˆj(x) defined in (10) by solving (9). Note
that it suffices to consider angle-based RD-Learning since binary RD-Learning is a special case of
angle-based RD-Learning. Denote δˆ = (δˆ1, . . . , δˆk)
T . The goal of our theoretical study is to obtain
the convergence rate for the prediction error (PE) of δˆ, defined by
PE(δˆ) = E
k∑
j=1
(
δˆj(X)− δj(X)
)2
,
where the expectation is with respect to X. Note that since δˆ depends on the training data,
PE(δˆ) is a random quantity. We consider linear models and non-linear models separately.
Before we present the main results, we make two additional assumptions for the two estimators
pˆj(x) and mˆ(x).
Assumption 2. Given estimator pˆj, we have ‖pˆ−1j (x)− p−1j (x)‖∞ ≤ rp with constant rp > 0 .
Assumption 3. Given estimator mˆ, we have ‖mˆ(x)−m(x)‖∞ ≤ rm and |Y − mˆ(X)| ≤ Cm with
rm > 0 and Cm > 0.
Assumptions 2 and 3 state that the estimation error for pˆ−1j (x) and mˆ(x) are bounded with
rp and rm characterizing the accuracy for both estimators. Recall that p˜j(x) and m˜(x) are the
limiting functions of pˆj(x) and mˆ(x) in Theorem 2. The case of p˜j(x) = pj(x) corresponds to
rp  rm; the case of m˜(x) = m(x) corresponds to rm  rp.
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3.3.1 Linear Function Space
We consider a linear function space F with a bounded L1 norm:
F = F(p, s) , {f = (f1, . . . , fk−1)T ; fj(x) = xTβj + β0j, j = 1, . . . , k − 1,
k−1∑
j=1
‖βj‖1 ≤ s}.
Without loss of generality, we bound each covariate in [−1, 1] for simplicity. The result still holds
if we bound each covariate in [−B,B] for any large number B > 0.
Assumption 4. X ∈ X = [−1, 1]p.
Theorem 3. Denote pn as the dimension of the data which may depend on sample size n. Let
F = F(pn, sn) and τn = (n−1 log pn)1/2 → 0 as n→∞. Under Assumptions 1 to 4, we have
PE(δˆ) ≤ O (max{(Cm + sn)2τn log τ−1n ,min{r1, r2}, dn}) ,
almost surely, given estimators pˆj(·) and mˆ(·), where r1 = (Cm + sn)2rp, r2 = (1 + rp)r2m, and
dn = inff∈F(pn,sn) ‖f − f ∗‖22.
Remark 1. Theorem 3 claims that the order of PE(δˆ) is determined by three terms. The first
term is the estimation error similar to the excess risk in the classification literature. As n→∞,
the term will vanish for fixed sn, while for fixed n and pn, it increases as sn →∞ indicating a more
complicated function space. The second term is determined by the accuracy of the two preliminary
estimators pˆj(·) and mˆ(·). Specifically, r1 describes the error from pˆj(x) while r2 describes the
error from mˆ(x). This term is small as long as either rp or rm is small, corresponding to the case
when pˆj(x) or mˆ(x) is accurate. Hence, this term reflects the “double robustness” property of the
proposed estimator. The third term dn is the approximation error of the function space F(pn, sn),
and it will decrease as sn increases in general. The choice of sn represents a trade-off between the
three terms.
Remark 2. By Theorem 3, RD-Learning improves D-Learning in the following two aspects.
Firstly, the second term in the upper bound of PE(δˆ) offers an additional way to decrease the
error. Note that D-Learning is a special case of RD-Learning with mˆ ≡ 0, which means r2 is
a large number. Therefore, for D-Learning to work well, r1 must be small. On the other hand,
RD-Learning offers a good ITE as long as either r1 or r2 is small. Secondly, the estimator of
RD-Learning has a smaller variance than that of D-Learning. This is because by replacing yi in
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D-Learning with yi − mˆ(xi), the upper bound Cm for |Y − mˆ(X)| in Assumption 3 also becomes
smaller in general, which further reduces the first term in PE(δˆ). This explains the narrower
confidence bands of RD-Learning in Figure 1.
Theorem 3 is a general statement for the convergence rate of PE(δˆ). It neither makes assump-
tions on the magnitude of rp and rm which have impacts on the second term, nor assumes the
true treatment effect falls in a particular function space F which influences the third term. If we
assume one of rp and rm is zero, the second term can be ignored. For example, in clinical trial
pj(x) is known so pˆj(x) = pj(x) and rp = 0. If we further assume δj(x) to be a linear function that
only depends on finite many covariates for each j, the third term can be also eliminated. Since in
that case, there exists a finite p∗ and s∗ such that the true population minimizer f ∗ belongs to the
F(pn, sn) as long as the function space we consider is large enough so that pn ≥ p∗ and sn ≥ s∗.
In this case, the third term dn = 0 for sufficient large n. The result is given in Corollary 1.
Corollary 1. Let F = F(pn, sn) and τn = (n−1 log pn)1/2 → 0 as n → ∞. Suppose the true
treatment effect δj(·) depends on finite many covariates for each j ∈ A. Under Assumptions 1 to
4, if either rp = 0 or rm = 0 holds, then we have
PE(δˆ) ≤ O(τn log τ−1n ),
almost surely.
From Corollary 1, we first observe that the convergence of PE(δˆ) requires that pn increases with
the order at most exp(n). Secondly, since O(log x) < O(xt) for all t > 0, PE(δˆ) ≤ O(τ 1−tn ) for any
small positive t. This implies that the upper bound of PE(δˆ) is almost O(τn) = O
(
(n−1 log pn)1/2
)
.
Furthermore, when pn is a fixed number, i.e., pn = O(1), the rate is almost O(n−1/2). These results
are coincident with most of the classical LASSO theory.
3.3.2 Reproducing Kernel Hilbert Space
We consider F to be a Reproducing Kernel Hilbert Space (RKHS) to demonstrate the results
for non-linear learning. The “kernel trick” has been successfully used in many other methods like
penalized regression and Support Vector Machine (SVM). There is a vast literature on RKHS. One
can refer to Scholkopf and Smola (2001), Steinwart et al. (2007), Hofmann et al. (2008), Trevor
et al. (2009) for more details.
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Let HK be a RKHS with kernel function K(·, ·). By the Mercer’s theorem, K has an eigen-
expansion K(x,x′) =
∑∞
i=1 γiφi(x)φi(x
′) with γi ≥ 0 and
∑∞
i=1 γ
2
i <∞. Any function in HK can
be written as f(x) =
∑∞
i=1 ciφi(x) under the constraint that ‖f‖2HK =
∑∞
i=1 c
2
i /γi < ∞. Define
the function space F as
F = F(s) , {f = (f1, . . . , fk−1)T ; fj = f ′j + bj, j = 1, . . . , k − 1,
k−1∑
j=1
‖f ′j‖2HK ≤ s2}.
Note that as in the linear case, the penalty term does not include the intercept term bj. Rewrite
the solution to (9) under such F as fˆ = fˆ ′ + bˆ where fˆ ′ = (fˆ ′1, . . . , fˆ ′k)T with f ′j ∈ HK . By the
representer theorem (Wahba, 1990), fˆ ′j can be represented by
fˆ ′j(x) =
n∑
i=1
K(xi,x)βˆij,
and the penalty term is written as ‖fˆ ′j‖2HK =
∑n
i=1
∑n
l=1K(xi,xl)βˆijβˆlj.
When developing RKHS theory, the following assumption is usually made.
Assumption 5. The RKHS HK is separable and supxK(x,x) = B <∞.
The separability of the RKHS is commonly assumed in many papers concerning RKHS. A
bounded kernel ensures that the rate of PE(δˆ) does not explode. It naturally holds for some
popular kernels like Gaussian radial basis kernel, where B = 1. In general, it requires that X can
be covered by a compact set.
Theorem 4. Let F = F(sn). Under Assumptions 1, 2, 3, and 5, we have
PE(δˆ) ≤ O (max{(Cm +Bsn)2n−1/2 log n,min{r1, r2}, dn}) ,
almost surely, given estimators pˆj(·) and mˆ(·), where r1 = (Cm + Bsn)2rp, r2 = (1 + rp)r2m, and
dn = inff∈F(sn) ‖f − f ∗‖22.
Remark 3. Similar to Theorem 3, there is a trade-off between the estimation error, the approx-
imation error, and the error from pˆj and mˆ for kernel learning. sn is the tuning parameter to
balance these three terms. The result also shows that compared to D-Learning, RD-Learning still
enjoys a better convergence rate through a smaller rm and Cm.
Theorem 4 can be simplified in some special cases. Firstly, the second term can be ignored when
rp or rm is negligible (for example, in clinical trails). Secondly, by assuming the approximation
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error dn ≤ O(s−qn ) for some q > 0, which is standard in the literature on RKHS (Smale and Zhou,
2003), we have a neat convergence rate by appropriately choosing sn, shown in Corollary 2.
Corollary 2. Let F = F(sn). Suppose dn = inff∈F(sn) ‖f − f ∗‖22 ≤ O(s−qn ) for some q > 0.
Under Assumption 1, 2, 3, and 5, if either rp = 0 or rm = 0 holds, then by choosing sn =
O
(
(n1/2 log−1 n)
1
q+2
)
, we have
PE(δˆ) ≤ O
(
n−
q
2q+5
)
,
almost surely.
According to Corollary 2, the convergence rate of PE(δˆ) approaches toO (n−1/2) for sufficiently
large q, corresponding to the case that f ∗ can be well approximated by a function in F(sn). This
result is consistent with most of the learning theories under the kernel setting.
4 Statistical Inference with Known Propensity Score
In this section, we consider the case when the propensity score pj(x) is known for each j ∈ A.
A typical example is clinical trials, where the treatments are assigned to patients randomly with
a fixed probability given x. In this case, we propose a consistent estimator for the main effect
m(x), which, according to the theories in Section 3.3, helps to reduce the variance of the treatment
effect estimator δˆj(x). A more fundamental contribution we make in this setting is an unbiased
estimator for the treatment effect δj(x) which is allowed by the known propensity score. We also
derive its asymptotic normality which is useful for constructing confidence intervals.
4.1 A Direct Method in Estimating the Main Effect
The RD-Learning framework we proposed in Section 3 is a two-step procedure. While the dis-
cussion so far focuses on the second step, i.e., estimating the treatment effect δj(x), we note that
the first step, i.e., estimating the main effect m(x), is also important.2 The theoretical studies in
Section 3.3 show that an accurate mˆ(x) reduces the variance of δˆj(x). Moreover, the estimation
of the main effect has its own value. For example, in biomedical studies, it can help researchers
to identify prognostic biomarkers (Kosorok and Laber, 2019).
2There is no need to estimate pj(x) in this case since we assume the propensity score is known.
13
A common method to estimate the main effect is Q-Learning. One first estimates each µj(x)
for j ∈ A separately, and then estimates m(x) by taking their average. However, this main effect
estimator may be inconsistent if µj(x) is mis-specified for some j. In addition, since the estimation
of each µj(x) depends on only a portion of the data, i.e., {(xi, ai, yi); ai = j}, the estimator may
suffer a large variance when there are very few observations in some treatment arms.
We propose to estimate the main effect using all the data points at the same time using weighted
least square. This estimator is motivated by the important observation that under model (8),
E
[
1
pA(x)
(Y − g(x))2
∣∣∣X = x] = E[ k∑
j=1
(Y ∗(j)− g(x))2
∣∣∣X = x] = k∑
j=1
(µj(x)−g(x))2+kσ2(x),
and the fact that m(x) = k−1
∑k
j=1 µj(x) = argming(x)∈R
∑k
j=1(µj(x)− g(x))2.
Based on these observations, we propose to estimate the main effect using
mˆ = argmin
g∈G
n∑
i=1
1
pai(xi)
(yi − g(xi))2, (11)
where G is an appropriate function space. Theorem 5 below implies that this estimator is consistent
if m ∈ G.
Theorem 5. Suppose the model (8) holds. Under Assumption 1,
m ∈ argmin
g∈{X→R}
E
[
1
pA(X)
(Y − g(X))2
]
.
Compared to the Q-Learning based method, the proposed method uses all the data to fit a
single estimator. Besides, this estimated adopts the form of weighted least square, which can be
easily generalized to and solved by many existing regression methods, such as LASSO, (kernel)
ridge regression, generalized additive model, gradient boosting, and so on.
4.2 Unbiased Treatment Effect Estimator
In this section we focus on statistical inference of treatment effects by RD-Learning, under the
special case that pˆj(x) in the RD-Learning estimator is replaced the known propensity score pj(x)
for each j ∈ A.
We start from the binary case under model (1). By assuming δ(x) = xTβ, the estimator βˆ by
RD-Learning is given by (4). However, we have to point out that this estimator is biased unless
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p1(xi) = 1/2 or mˆ(xi) = m(xi) for each i. In fact, according to (5), the bias term can be explicitly
written as
bias(βˆ) = E
(
βˆ
)− β = E((XTP−1a X)−1XTAP−1a r(X)).
Remark 4. To see why βˆ is biased, consider a simple case where n = 3, X = 13, and p1(x) = p1 ,
2/3. Suppose we have an estimator mˆ(x) with the residual term r(x) = m(x)−mˆ(x) = 1. It can be
checked that bias(βˆ) = E
(
(
∑3
i=1 p
−1
Ai
)−1
∑3
i=1Ai/pAi
)
, where the expectation is taken with respect
to {Ai}. Note that there are 8 possible assignments for {Ai}: (1, 1, 1), (1, 1,−1), . . . , (−1,−1,−1),
with probabilities (2/3)3, (2/3)2(1/3), . . . , (1/3)3. So by computing this expectation explicitly, we
have bias
(
βˆ
)
= 17/135 6= 0 in this toy example.
To remove the bias completely, we modify (4) as
β˜ =
1
2
(XTX)−1XTAP−1a (y − mˆ(X)). (12)
The original RD-Learning estimator (4) was based the following normal equation of (3),
XTP−1a Xβ = X
TAP−1a (y − mˆ(X)). (13)
Since we assume pai(xi) is known, we can verify that the expectation of the left hand side of (13)
with respect to A for any β is
E
(
XTP−1a Xβ | X
)
= 2XTXβ.
Then by replacing the left hand side of (13) by its expectation, we derive the modified estimator
(12). One can check that the bias of the modified estimator is 0.
In the multi-arm case (8), we use the angle-based approach to estimate a (k − 1)-dimensional
decision function f(x) = (xTβ1, . . . ,x
Tβk−1)T first and then use 〈Wj,f(x)〉 to estimate δj(x).
Specifically, we solve
{βˆ1, . . . , βˆk−1} ∈ argmin
{βj}
1
n
n∑
i=1
1
pai(xi)
(yi − mˆ(xi)− 〈Wai ,f(xi)〉)2 .
Denote Bˆ(p+1)×(k−1) as (βˆ1, . . . , βˆk−1). By using the similar trick as described above for the binary
case, we modify Bˆ to be an unbiased B˜. The modified estimator for the treatment effect is then
δ˜j(x) = 〈Wj,xT B˜〉 = xT γˆj where γˆj , B˜Wj. We can verify that
γˆj = (X
TX)−1XTdiag
(
1[ai = j]− 1
k
)
P−1a (y − mˆ(X)). (14)
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Theorem 6. Let {(xi, ai, yi)}ni=1 be a random sample with pj(xi) > 0 for all i and j. Assume
the model (8) holds with the true treatment effect δj(x) = x
Tγj and columns of X are linear
independent. Given an estimator for the main effect mˆ(x) < ∞, denote γ = (γT1 , . . . ,γTk )T and
its estimator γˆ = (γˆT1 , . . . , γˆ
T
k )
T with γˆj defined in (14). Then we have
E(γˆ) = γ.
Furthermore, let r(xi) = m(xi)− mˆ(xi). Suppose xi, r(xi), p−1j (xi), and σ2(xi) are uniformly
bounded. Denote Pk×k(x) = diag (pj(x)), δ(x) = (δ1(x), . . . , δk(x))T , and C(k) = I−k−1J, where
J is a k × k matrix with all elements equal to 1. If
V = lim
n→∞
n−1XTX,
M = lim
n→∞
n−1
n∑
i=1
(
C(k)diag
(
(r(xi) + δj(xi))
2
)
P−1(xi)C(k)− δ(xi)δ(xi)T
)⊗ (xixTi ) ,
Σ = lim
n→∞
n−1
n∑
i=1
(
C(k)σ2(xi)P
−1(xi)C(k)
)⊗ (xixTi )
are finite and positive definite, then
√
n(γˆ − γ) D−→ N (0, (J⊗V−1) (M + Σ) (J⊗V−1)) .
Theorem 6 implies γˆj is an unbiased estimator of γj, and it is
√
n-consistent. Moreover, its
variance is determined by two matrices M and Σ, where M depends on the estimator mˆ(·), and
Σ on the variance of . Note that in D-Learning, r(xi) in M becomes m(xi), which is larger
than r(xi) in RD-Learning. This also explains why RD-Learning has a smaller variance than
D-Learning.
Remark 5. In the binary case, β = γ1 = −γ2. From Theorem 6, the variance of β˜, defined in
(12), can be written as
Var(β˜) = (XTX)−1XTdiag
(
c(xi)
(
(r(xi) + δ1(xi))
2 + σ2(xi)
)− δ21(xi))X(XTX)−1,
where c(x) = p−11 (x)(1 − p1(x))−1/4. Observe that c(x) is minimized when p1(x) = 1/2. This
implies that the estimator renders the smallest variance in completely randomized design given
other terms the same. In fact, when p1(xi) = 1/2, σ
2(xi) = σ
2 for all i, and mˆ(·) = m(·), we
have Var(β˜) = σ2(XTX)−1, which is the same variance as in the classical linear regression model.
Theorem 6 can be used for constructing the confidence interval for γ (or the treatment effect δj).
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However, the variance of γˆ involves two unknown terms δ(xi)δ(xi)
T and (r(xi)+δj(xi))
2+σ2(xi).
We may replace them by their consistent estimators, as in the heteroskedasticity literature (White
et al., 1980). Specifically, δj(x) in the first term can be estimated by δˆj(xi) = x
T
i γˆj. For the
second term, note that
E
[
(Y − mˆ(x)− δA(x) + δj(x))2 |X = x
]
= E
[
(r(x) + δj(x) + )
2 |X = x]
= (r(x) + δj(x))
2 + σ2(x).
This implies that we may estimate (r(xi) + δj(xi))
2 + σ2(xi) by (yi − mˆ(xi)− δˆai(xi) + δˆj(xi))2.
5 Simulation Studies
We compare the proposed method with four other popular methods in estimating the treatment
effect. They are Q-Learning (Qian and Murphy, 2011), Robust Learning (Shi et al., 2016; Nie
and Wager, 2017, R-Learning), causal forests (Wager and Athey, 2018) and D-Learning (Chen
et al., 2017; Qi et al., 2018). Note that except Q-Learning and D-Learning, all other methods are
two-step procedures, where the first step involves estimating either m(x) or E(Y |X = x). We fix
the number of covariates to be 100, where X1, X2 and X3 are i.i.d. from N(0, 3), and X4, . . . , X100
are i.i.d. from Uniform(0, 1). For each simulation setting, we let the number of observations to be
n = 50, 100, and 200. The prediction error of δˆ1 is reported based on a testing set of size 400.
Case I: It is a two-arm design, with
µ1(x) = 2 cos(x1 + pi/4) + x1 − tanh(x2) and
µ2(x) = 2 cos(x1 + pi/4) + 2x1 − tanh(x2).
The treatment assignment depends on x. Specifically, p1(x) = 0.2 + 0.61[x1 < 0]. Since µ1(·),
µ2(·) and the main effect are non-linear functions of x, we consider kernel functions in Q-Learning,
and in the first step of causal forests, R-Learning, and RD-Learning. On the other hand, because
the treatment effect is linear, we use linear models with an L1 penalty in D-Learning as well as in
the second step of R-Learning and RD-Learning.3
Case II: This is an example to test the robustness of the proposed method against mis-
3By default, the second step of causal forest uses a non-linear regression tree.
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specification of the main effect. In this case, we have
µ1(x) = tanh(x1)− 4/(1 + exp(x2 − x1)) + 3 and
µ2(x) = tanh(x1) + 4/(1 + exp(x2 − x1)).
It is a randomized design with p1(x) = 1/5. Both the main effect and the treatment effect are non-
linear. Hence we are supposed to use non-linear function spaces for all the methods. However,
to test the robustness of the proposed RD-Learning method, we use linear models with an L1
penalty to estimate the main effect in the first step and kernel ridge regression in the second step.
For comparison purposes, we adopt the same function spaces (linear and kernel) in all the other
two-step procedures, and use kernel ridge regression in the one-step Q-Learning and D-Learning.
Case III: This is an example to test the robustness of the proposed method against mis-
specification of the propensity score. In this example,
µ1(x) = x1 − x2 + x3 and µ2(x) = 2x1 − x2.
The propensity score is defined as p1(x) = 2/(2 + exp(x1)). In this case, we use linear models
with an L1 penalty in all methods and both steps. To test the robustness of RD-Learning, we
deliberately use a wrong propensity score pˆ1(x) = 1/2 instead. For comparison, we let pˆ1(x) = 1/2
in the other methods.
Case IV: This is a three-arm design, with
µ1(x) = (x
2
1 + x
2
2 + x
2
3)/3 + x1 − x2,
µ2(x) = (x
2
1 + x
2
2 + x
2
3)/3 + x2 − x3, and
µ3(x) = (x
2
1 + x
2
2 + x
2
3)/3 + x3 − x1.
The propensity score depends on x. Specifically,
(p1(x), p2(x), p3(x)) =

(1/2, 1/4, 1/4), for x1 ≥ x2 and x1 ≥ x3
(1/4, 1/2, 1/4), for x2 > x1 and x2 ≥ x3
(1/4, 1/4, 1/2), for x3 > x2 and x3 > x1.
This setting is similar to Case I in the sense that it has a non-linear main effect and a linear
treatment effect. We use the same function space as in Case I. We do not report the results
by causal forests and R-Learning because currently these two methods cannot be applied to the
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multi-arm case directly.
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Figure 2: The average prediction error of δˆ1 based on 200 replications with standard error by different
methods. In all cases RD-Learning has the best performance.
Estimation of the treatment effect
From Figure 2, we first observe that the proposed RD-Learning method has the smallest
prediction error in most scenarios. Secondly, Q-Learning and D-Learning typically have a larger
standard error than the two-step procedures. This is consistent with the well known intuition (see
also Theorem 3 and 4) that by replacing yi with yi − mˆ(xi), the variance of estimators can be
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reduced. Thirdly, we see that RD-Learning is indeed “doubly robust” against mis-specification of
the main effect (in Case II) and the propensity score (in Case III). For the discussion below, we
only focus on the three best methods, namely, R-Learning, Q-Learning, and RD-Learning. Recall
that Case II is an example where we deliberately use a wrong function space for the main effect.
Since R-Learning is robust against this kind of mis-specification, it has a better performance than
Q-Learning. However, in Case III where we deliberately use a wrong propensity score, R-Learning
has a much worse performance than Q-Learning since it relies on a correctly-specified pˆj(·). But
RD-Learning is as good as, and in many cases, much better than any of these two in both settings.
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Figure 3: Boxplots for the prediction error of mˆ based on 200 replications in Case I (left) and Case IV
(right). The proposed method has a smaller error than Q-Learning in estimating the main effect.
Estimation of the main effect
In addition to the treatment effect, we also report the estimator for the main effect using the
proposed direct method in Section 4.1 and the Q-Learning method that estimates each µj and
takes the average. Figure 3 shows the result based on the same simulation data in Case I and
Case IV. We observe that by using all the data at the same time and using propensity score as
the weight, the proposed method has a better performance compared to the Q-Learning method.
Confidence Interval for the Coefficients
Finally, we compute the unbiased estimator defined by (14) using the data in Case I and
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Case IV and construct the confidence interval for the coefficient of an important covariate x1.
The relation between the nominal confidence level and the empirical coverage rate, defined as the
proportion of the confidence intervals that cover the true parameter, is shown in Figure 4. Most of
the empirical coverage rates are close to the nominal confidence levels, supporting the asymptotic
distribution derived in Theorem 6. In the worse case scenario, for nominal level 95%, the resulting
confidence interval missed it by 1.5% (in Case IV).
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Figure 4: Nominal confidence levels ranging from 90.1% to 99.9% and the empirical coverage rate based
on 200 replications in Case I (left) and Case IV (right) with sample size n = 200. The 45◦ straight line
represents the ideal situation.
6 Real Data Analysis
In this section we apply RD-Learning on a real dataset from the AIDS Clinical Trials Group
Study 175 (Hammer et al., 1996, ACTG175). The dataset includes 2,139 HIV-1 infected subjects.
They were randomly assigned with equal probabilities to one of the four treatments: zidovudine
(ZDV) only, ZDV with didanosine (ddI), ZDV with zalcitabine (ddC), and ddI only. The endpoint
(outcome) we consider is the change of the CD4 cell count (per cubic millimeter) at 20± 5 weeks
from the baseline. Note that a decrease in the number of CD4 cell count usually implies a
progression to AIDS. In other words, a larger value indicates a better outcome.
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To apply the proposed RD-Learning method, we first estimate the main effect using the direct
estimator proposed in Section 4.1 based on the 18 variables that were measured prior to the
initiation of the study. Specifically, we use the generalized additive model (GAM) to solve the
weighted least square problem (11). The best GAM model is selected through stepwise AIC.
For the second step in which the treatment effect is estimated, we follow the analysis of Fan
et al. (2017) and Qi et al. (2019) and consider only 12 variables measured at baseline as the
covariates for each subject. Five of 12 covariates are continuous: age (years), weight (kilogram),
Karnofsky score (on a scale of 0-100), CD4 cell counts (per cubic millimeter), and CD8 cell counts
(per cubic millimeter). The rest seven are binary: hemophilia (0=no, 1=yes), homosexual activity
(0=no, 1=yes), history of intravenous drug use (0=no, 1=yes), race (0=white, 1=non-white),
gender (0=female, 1=male), antiretroviral history (0=naive, 1=experienced), and symptomatic
indicator (0=asymptomatic, 1=symptomatic).
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Figure 5: 5-fold cross validation scores of V (dˆ) based on 400 replications by different methods for
ACTG175 data. RD-Learning has the highest empirical value on average.
We compare the performance of RD-Learning with Q-Learning and D-Learning through 5-fold
cross validation. However, since it is a real data set in which the true treatment effect is not
observed, the prediction error cannot be calculated. Instead of evaluating the prediction error,
we first derive the estimated optimal ITR of each method by dˆ(xi) = argmaxj δˆj(xi). Then we
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calculate the empirical expected outcome under the obtained ITR dˆ, defined as
V (dˆ) =
∑n
i=1
(
yi1
[
ai = dˆ(xi)
]
/pai(xi)
)
∑n
i=1
(
1
[
ai = dˆ(xi)
]
/pai(xi)
)
(Murphy et al., 2001; Zhao et al., 2012). Note that in this application V (dˆ) measures the average
increase in CD4 cell counts (per cubic millimeter) by taking the recommended treatment. Larger
value V (dˆ) is preferred. Finally, we replicate the procedure for 400 times and the boxplot of V (dˆ)
is shown in Figure 5.
From Figure 5, we observe that RD-Learning yields the largest value, and V (dˆ) of D-Learning is
slightly higher than that of Q-Learning. This implies that patients would benefit more by following
the recommended treatment that is based on the treatment effect estimated by RD-Learning.
Table 1: Significant coefficients of each treatment effect for ACTG175 Data. Each column stands for a
treatment arm, and each row corresponds to a covariate. Significant coefficients and levels identified by
each method are marked.
ZDV ZDV+ddI ZDV+ddC ddI
Age Q***, D**, RD*** Q**, D*, RD**
Weight
Hemophilia
Homosexual Q*, D*, RD* Q*, D, RD*
Drug use Q D, RD
Karnofsky D**, RD RD
Race Q*, D*, RD*
Gender
Antiretroviral
Symptomatic
CD4 Baseline Q**, D***, RD* Q**, D*, RD**
CD8 Baseline
* “Q”, “D”, and “RD” stand for Q-Learning, D-Learning, and RD-Learning, respectively.
* Significant code example: “Q” for p-value < 0.1 using Q-Learning. Similarly, “Q*” for
p-value < 0.05, “Q**” for p-value < 0.01, and “Q***” for p-value < 0.001.
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To identify important biomarkers, we estimate the coefficients of the 12 covariates by (14) and
compute their standard errors. The significant level of each variable using Q-Learning, D-Learning,
and RD-Learning is marked in Table 1.4
From Table 1, we observe that these three methods give similar results in general. The different
patterns of those significant coefficients across different treatment effects suggest that heterogeneity
does exist in these four treatment arms. For example, if we project the data on two important
biomarkers “age” and “CD4 baseline” and mark each point according to its optimal treatment
assignment estimated by RD-Learning, we can visualize how the treatment effects depend on these
two biomarkers. In Figure 6, we first notice that the treatment ZDV is inferior to the other three
treatments. This result is consistent with previous findings (Hammer et al., 1996; Fan et al., 2017;
Qi et al., 2019). Furthermore, for the majority of the patients, ZDV with ddI is the best treatment.
ZDV with ddC is most effective on young patients (age < 25), and ddI alone is better than the
others for patients who have more CD4 cells (CD4 counts > 500 per cubic millimeter) at baseline.
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Figure 6: ACTG175 data projected on “age” and “CD4 baseline”, with the best treatment based on the
estimated treatment effect by the RD-Learning marked by different colors and symbols.
4Q-Learning is a linear regression based method with standard significance score. Since D-Learning can be
viewed as a special case of RD-Learning, we derive the significance level using our method in Section 4.2.
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7 Conclusion
In this work, we propose a doubly robust method RD-Learning to estimate ITE under two-arm and
multi-arm settings. The estimated ITE is consistent if either the model for the main effect or the
model for the propensity score is correctly specified. The proposed framework is flexible enough
that it can incorporate with existing base procedures such as LASSO, kernel ridge regression,
generalized additive model, and so on. We also propose a direct estimation approach for the main
effect and provide statistical inference tools for the treatment effects when the propensity scores
are known.
There are a few possible future research directions based on this work. Firstly, by modifying
the quadratic loss function, the framework can be extended to other types of outcome, such as
binary outcome and survival outcome (Chen et al., 2017; Qi et al., 2019). Secondly, one may want
to improve our two-step procedure to a one-step method based on (9), i.e., estimating pj(x), m(x),
and δj(x) simultaneously. Such ITE estimator would still enjoy a doubly-robust property while the
convergence rate of PE(δˆ) may be different from the proposed method. Thirdly, the method can
applied to dynamic treatment regime (Murphy, 2003; Robins, 2004) by considering a multi-stage
optimization problem, so that a sequence of treatment effects and the optimal treatment rules can
be estimated robustly in a multi-stage clinical trial. Finally, based on the asymptotic distribution
in Theorem 6, one can consider a new framework for the set-valued treatment rule (Laber et al.,
2014; Meng et al., 2020). That is, several treatments with similar outcomes are recommended to
a patient which allows patients to tailor the best treatment for themselves.
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